ALK and adenocarcinoma: Molecular analyses to detect epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangement identify specific subgroups of patients [5, 6], often younger and non-smokers compared to other forms of adenocarcinoma [7–9].